Target intelligence / Profile preview

Peroxisome assembly protein 26 (PEX26)

Target
PEX26
Molecular classification
Peroxisomal membrane protein, Peroxin family protein, Not a receptor, Not an enzyme, Not a transporter, Not a transcription factor
01

Overview

Peroxisome assembly protein 26 (PEX26) is an integral membrane protein of the peroxisome that serves as a membrane anchor for the PEX1–PEX6 AAA ATPase complex, which is critical for peroxisomal matrix protein import and peroxisome biogenesis. PEX26 is required for docking PEX1 and PEX6 to the peroxisomal membrane, enabling the extraction of the PEX5 import receptor from the peroxisome following cargo delivery. It is involved in additional processes such as peroxisomal division, proliferation, and various aspects of lipid metabolism, including fatty acid β-oxidation and plasmalogen synthesis. Loss-of-function mutations in PEX26 cause a subset of peroxisome biogenesis disorders, including Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease, which are characterized by impaired peroxisomal matrix protein import and broad metabolic dysfunction. Several alternatively spliced isoforms exist, some of which can partially complement PEX26 deficiency. PEX26 is not a direct therapeutic target but is a key node in peroxisomal biogenesis and disease, with its deficiency resulting in variably severe neurological and metabolic disorders.

Other names
Peroxin-26Peroxisomal biogenesis factor 26FLJ20695PBD7APBD7BPEX26M1TPex26pM1Tperoxisome biogenesis disorder complementation group 8 proteinperoxisome biogenesis disorder complementation group A protein
02

Mechanism of action

null

03

Biological functions

Peroxisomal protein importmembrane assemblyorganelle division and proliferationmatrix protein importfatty acid metabolism (including very long-chain fatty acids and plasmalogen biosynthesis)maintenance of peroxisome architecture
04

Disease associations

Peroxisome biogenesis disorders (especially Zellweger syndrome spectrum: Zellweger syndrome, neonatal adrenoleukodystrophy, infantile Refsum disease)Neurodegenerative disease (as part of peroxisome-related disorders)Other inborn errors of metabolism

Beyond the preview

Go deeper on Peroxisome assembly protein 26 (PEX26).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peroxisome assembly protein 26 (PEX26).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call